MSN and Cognitive impairment: In conclusion, the present study demonstrates that BSHX prescription effectively improves diabetes-induced cognitive impairment and cerebral microangiopathy through inhibition of AGEs-RAGE induced expression of RhoA/ROCK/moesin signaling pathway.